£475.00

When it comes to cancer, early awareness is everything—and for men, three of the most common types often go undetected until it’s too late. The Male Multi Cancer Risk Home Test Kit & Prevention Plan puts the power of foresight into your hands with a simple, saliva-based test you can do at home.

Using cutting-edge Polygenic Risk Score (PRS) technology, this test analyses your DNA to determine your inherited risk of prostate cancer, bowel cancer, and melanoma—three cancers that together account for thousands of male deaths in the UK every year.

You won’t just get numbers. You’ll get a clear, science-backed prevention plan that helps you understand your risk, when to start screening, and the lifestyle changes that can reduce your risk going forward.

  • 1 in 2 people in the UK will be diagnosed with cancer during their lifetime (Cancer Research UK, 2023), and men are often less likely to engage with preventative care.
  • Prostate cancer is the most common cancer in men, while bowel cancer is the second leading cause of cancer death.
  • Melanoma cases in men are on the rise, particularly in those over 50.

This test allows you to take a proactive approach to your health – before symptoms appear.

 

Description

  • Discover your genetic risk level for prostate cancer, bowel cancer, and melanoma
  • Get personalised guidance on when to start screening and how often
  • Learn actionable steps to reduce your risk
  • Powered by clinical-grade, at-home saliva-based genetic testing
  • Recommended for men aged 40 and above

Testing for –

Prostate Cancer Risk – Prostate cancer is the most common cancer in men—but when caught early, it’s also one of the most treatable.

Colorectal (Bowel) Cancer Risk – Colorectal cancer is the fourth most common cancer in the UK – and the second biggest cancer killer. But it doesn’t have to be.

Melanoma Cancer Risk – Skin cancer is the fifth most common cancer in the UK, and melanoma is the deadliest form. But the good news? When caught early, almost 100% of cases are treatable (Cancer Research UK, 2023).

 

Reviews

There are no reviews yet.

Be the first to review “Male Multi Cancer Risk”

Your email address will not be published. Required fields are marked *